Position in PFE
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$10,662,310
-$1,591,015 QoQ
Shares Held
442,787
+1.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#408
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. PFE ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
188,484 | $226,073,382 | |
| 2 | ABBV |
AbbVie Inc.
|
422,207 | $106,244,168 | |
| 3 | MRK |
Merck & Co., Inc.
|
381,609 | $49,036,756 | |
| 4 | JNJ |
Johnson & Johnson
|
150,964 | $38,340,326 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
195,795 | $24,736,739 | |
| 6 | PFE |
Pfizer Inc
This page
|
442,787 | $10,662,310 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
102,223 | $5,890,089 | |
| 8 | AMGN |
Amgen Inc
|
8,321 | $3,013,200 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,662,310 | 442,787 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $12,253,325 | 436,372 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,829,482 | 434,919 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $11,309,374 | 443,853 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $11,267,576 | 464,834 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,507,823 | 493,600 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $11,156,660 | 420,530 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $15,079,331 | 521,055 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,572,459 | 520,817 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,509,754 | 486,838 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,665,468 | 439,926 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $18,755,478 | 565,435 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $20,297,390 | 553,364 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,423,598 | 549,598 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $27,205,415 | 530,941 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $22,616,524 | 516,831 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $26,810,341 | 511,355 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $25,906,484 | 500,415 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $28,164,960 | 476,968 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $20,009,713 | 465,234 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,742,925 | 453,088 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $15,075,375 | 416,102 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,221,653 | 386,353 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $14,129,779 | 385,008 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,533,170 | 383,277 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $11,436,354 | 350,379 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||